...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Phase 3 Status with a European Regulatory Authority

Perhaps this rvx-208 trial approval will create momentum for approval in other European trials. Great to see these very positive achievements!

China may be next and should be expected given the 2 RVX patents and size and confidence of Hepalink.

This will be a very interesting week.

Cheers

Toinv

Share
New Message
Please login to post a reply